Biogen
BIIB
#673
Rank
$27.93 B
Marketcap
$192.16
Share price
-1.53%
Change (1 day)
-34.24%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total assets

Total assets on the balance sheet as of December 2023 : $26.84 B

According to Biogen's latest financial reports the company's total assets are $26.84 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Biogen - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2023-12-31$26.84 B9.33%
2022-12-31$24.55 B2.83%
2021-12-31$23.87 B-3.01%
2020-12-31$24.61 B-9.6%
2019-12-31$27.23 B7.69%
2018-12-31$25.28 B6.92%
2017-12-31$23.65 B3.39%
2016-12-31$22.87 B17.29%
2015-12-31$19.50 B36.26%
2014-12-31$14.31 B20.66%
2013-12-31$11.86 B17.11%
2012-12-31$10.13 B11.94%
2011-12-31$9.04 B11.83%
2010-12-31$8.09 B-5.37%
2009-12-31$8.55 B0.86%
2008-12-31$8.47 B-1.74%
2007-12-31$8.62 B0.89%
2006-12-31$8.55 B2.04%
2005-12-31$8.38 B-8.55%
2004-12-31$9.16 B-3.56%
2003-12-31$9.50 B361.43%
2002-12-31$2.05 B19.68%
2001-12-31$1.72 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$167.55 B 524.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$226.50 B 743.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$134.71 B 401.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$97.15 B 261.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$139.81 B 420.83%๐Ÿ‡ซ๐Ÿ‡ท France
$62.12 B 131.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.11 B-62.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.36 B-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.11 B-77.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.29 B-54.18%๐Ÿ‡บ๐Ÿ‡ธ USA